Men & Prostate Cancer

Prostate cancer is the most common male cancer in the UK and a critical topic in men’s health. Awareness and proactive measures can truly make a difference.

UK Stats at a Glance
• Around 55,100 new cases in the UK annually (2017–2019)—almost 150 men every day .
• That accounts for 28% of all new male cancer cases, and 14% of all cancers in both sexes .
• Average of 12,000 deaths per year—about 33 daily .
• Almost 78% survive at least 10 years, with higher survival in younger or less deprived men .
• Incidence is rising and projected to increase another 15% by 2040 .

Causes & Risk Factors

The precise cause is unclear, but several risk factors are well documented:
1. Age – Risk rises after age 50; most diagnoses between 75–79 years .
2. Ethnicity – Higher risk among Black men, lower among Asian men .
3. Family history & genetics – Affected father/brother doubles the risk; BRCA2 gene variations raise it significantly .
4. Obesity – Linked to advanced disease and higher mortality. Every 5 kg/m² BMI increase raises death risk by 15–20% .
5. Diet & hormones – High calcium intake, saturated fats, IGF‑1 hormone, and pesticide exposure may increase risk .

Prevention & Early Detection

While prostate cancer can’t yet be fully prevented, these steps can lower risk and aid early discovery:
• Healthy weight – Helps reduce aggressive prostate cancer risk .
• Active lifestyle & balanced diet – Regular exercise and a diet rich in fruit, vegetables, fish, soy, cruciferous veggies reduce risk .
• Cholesterol control – Statins may have a modest benefit .
• Screening awareness – PSA blood tests available from age 50 (or 45 for high-risk men), though not part of general UK screening .
• Know the signs – Difficulty urinating, blood in urine/semen, bone/back pain—seek GP advice early .

Diagnosis & Remedies
1. Tests: PSA blood test → MRI scan → biopsy.
2. Active surveillance: For low-risk cancers—regular monitoring to avoid overtreatment .
3. Focal therapies: Cryotherapy, HIFU for moderate-risk cases .
4. Surgery & radiotherapy: Standard for early-stage disease.
5. Hormonal therapy and chemotherapy: For advanced or metastatic cases .
6. Supportive care: Managing symptoms, improving quality of life—dietitians, physio, emotional support .

Taking Action Today
• Talk to your GP about PSA testing—especially if you’re over 50, have a family history, or are of Black African–Caribbean heritage.
• Maintain a healthy weight, stay active, and eat well.
• Learn the warning signs and act early—early detection greatly improves outcomes.
• Stay informed—UK guidelines are being reviewed to promote better screening tools like MRI .
• Add faith into the fight—seek God’s peace (Philippians 4:6–7) and invite brothers to walk the journey with you.

In Summary

Prostate cancer is common—and serious—but knowledge is power. By understanding risks, living smarter, and getting checked early, you increase your chances of recovery. Let faith and brotherhood be the backbone of your health journey.

Go deeper—talk to your GP, explore PSA testing, and lean on the Body of Christ for strength and courage.

Sources of Information
1. Cancer Research UK
• Prostate Cancer Statistics
• Covers UK-specific incidence, mortality, survival, risk factors, and prevention.
2. NHS (National Health Service)
• Prostate Cancer Overview
• Provides guidance on symptoms, causes, testing, treatment, and living with prostate cancer.
3. Prostate Cancer UK
• Risk Factors and Testing
• Offers detailed advice on PSA tests, early detection, Black men’s higher risk, and family history implications.
4. The Guardian
• Article: “Thousands take part in prostate cancer trial in bid to revolutionise detection”
• Read here
5. The Times (UK)
• Article: “Prostate cancer: what all men need to know”
• Read here
6. BMJ (British Medical Journal)
• Various reviews on PSA testing, screening trials, and treatment comparisons for early-stage cancer.
7. National Institute for Health and Care Excellence (NICE)
• NICE Guidelines on Prostate Cancer
• Covers diagnosis, staging, treatment options, and follow-up pathways in the UK.
8. Office for National Statistics (ONS)
• Cancer Registration Statistics, England
• Includes data on incidence by age group and region.
9. European Association of Urology (EAU)
• Guidelines and position papers on focal therapies, active surveillance, and emerging screening methods.

Shopping Cart
Scroll to Top